Sponsored by: Fujifilm

MRI: Page 112

Philips reports 3% decline in sales during Q3
By AuntMinnie.com staff writers
Philips Healthcare has recorded a 3% decline in sales on a comparable basis for its global Diagnosis & Treatment businesses during the third quarter of 2020, but this represents an improvement compared with the 9% fall in Q2, CEO Frans van Houten told a press briefing on October 19.
October 18, 2020
2019 12 18 18 21 0442 Philips Rsna 2019 400
Errors on prior MRI exams show need for specialty reads
By Kate Madden Yee
A high rate of discrepancies on primary body MRI exams acquired at outside institutions such as community hospitals shows a clear need for second exam interpretations by subspecialists when patients are transferred to a new center, according to a study published online October 14 in the American Journal of Roentgenology.
October 15, 2020
2020 08 14 16 38 7291 Mri Scanner2 400
ViewRay wins Ohio MRIdian Linac contract
By AuntMinnie.com staff writers
Image-guided radiation therapy vendor ViewRay has won a contract with an Ohio medical center for its MRIdian Linac for MRI-guided radiation therapy.
October 14, 2020
2019 09 17 16 42 0082 Viewray Astro 2019
Startup BrainKey offers brain MRI direct to consumers
By Kate Madden Yee
A California-based startup called BrainKey is offering MRI exams straight to consumers with the pitch that they can explore 3D models of their own brains. BrainKey's backers believe that the service will help consumers assess their brain health and could prompt early care for future ailments.
October 14, 2020
2019 09 30 21 18 3081 Mri Head 400
AuntMinnie.com MRI Insider
By Kate Madden Yee
October 12, 2020
4D MRI could be big leap forward for fetal heart imaging
By Theresa Pablos
Clinicians could have better information about fetal heart health thanks to a new imaging method developed by researchers from London. The team described how they used 4D MRI to measure volumetric blood flow in a paper published on October 5 in Nature Communications.
October 11, 2020
2016 10 12 11 02 26 66 Fetus Mri 400
Impaired blood flow linked to tau buildup in AD patients
By Kate Madden Yee
Using MR and PET imaging, researchers from the University of Southern California in Los Angeles have found a connection between impaired blood flow to the brain and tau protein buildup in patients with Alzheimer's disease (AD), according to a study published October 12 in the Journal of Neuroscience.
October 11, 2020
2020 10 09 20 42 8431 2020 10 12 Brain Tau 20201009205921
1st patient implanted in Medtronic's ELITE study
By AuntMinnie.com staff writers
Device manufacturer Medtronic announced the first patient was implanted in its evaluation of InterStim Micro system performance and safety (ELITE) study.
October 8, 2020
2020 10 09 19 56 6173 Bladder Urinary 3 D 400
Polarean seeks FDA nod for Xe-129-based lung MRI
By AuntMinnie.com staff writers
Polarean Imaging has submitted a new drug application to the U.S. Food and Drug Administration (FDA) for its drug-device combination that uses hyperpolarized xenon-129 (Xe-129) gas with MRI to visualize and quantify regional lung function.
October 6, 2020
2019 02 12 00 42 1003 Heart Lungs 400
Severe COVID-19 puts patients at risk of encephalopathy
By Kate Madden Yee
A third of patients hospitalized with COVID-19 experience various forms of encephalopathy, or altered mental states, including an inability to reason, difficulty concentrating, or memory loss, according to a study published October 5 in the Annals of Clinical and Translational Neurology.
October 6, 2020
2019 02 20 20 38 9544 Mri Brain Head 400
Presurgical cardiac stress testing on decline
By Kate Madden Yee
Presurgical cardiac stress testing is on the decline, according to a study published September 30 in JAMA Cardiology. The research suggests that efforts from professional organizations to curb unnecessary healthcare interventions through issuing guidelines has been successful.
October 5, 2020
2019 06 11 22 35 5932 Heart Pulmonary Trunk 400
Bayer touts Gadavist cardiac clinical study
By AuntMinnie.com staff writers
Bayer is touting the findings of a pair of phase III clinical studies investigating its Gadavist MRI contrast agent for identifying coronary artery disease.
October 4, 2020
2019 12 19 17 46 9582 Bayer Rsna 2019 400
Previous Page
Page 112 of 624
Next Page